Search Results 31-40 of 7814 for SC

  1. Publications - Stephanie C. Mavis, M.D., M.H.P.E. - Mayo Clinic

    Dyess NF, Carr CB, Mavis SC, Caruso CG, Izatt S, French H, Dadiz R, Bonachea EM, Gray MM. Implicit Bias and Health Disparities Education in the Neonatal ...

  2. Sumatriptan (subcutaneous route) - Mayo Clinic

    Skip to content. Mayo Clinic Home Page · Request appointment · Log in.

  3. Diseases and Conditions that Start with S - Mayo Clinic

    Sc ; SCAD. See. Spontaneous coronary artery dissection (SCAD) ; Scalded mouth syndrome. See. Burning mouth syndrome ; Scarlatina. See. Scarlet fever ; Schizophrenia ...

  4. Contact - Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    Sc., M.S.. Lymphoma Biostatistics and Data Science Laboratory; Mayo Clinic; Minnesota BioBusiness Center, Fifth Floor; 200 First St. SW; Rochester, MN 55905 ...

  5. A Study to Evaluate the Effectiveness, Safety, and Tolerability of Efgartigimod PH20 SC in Patients with Pemphigus - Mayo Clinic

    The primary purpose of this study is to assess the safety of extended treatment and retreatment with efgartigimod PH20 SC in patients with Pemphigus Vulgaris ( ...

  6. Churg-Strauss Syndrome Clinical Trials - Mayo Clinic Research

    The primary objective of the study is to evaluate the effectiveness of depemokimab 200 mg SC every 26 weeks compared with mepolizumab 300 mg SC every 4 ...

  7. Research - GI Stem Cell Research - Mayo Clinic Research

    ... SC). Research in Dr. Hayashi's lab seeks to unravel the molecular and epigenetic mechanisms of ICC-SC decline underlying aging-associated ICC depletion. By ...

  8. Sickle cell anemia - Diagnosis & treatment - Mayo Clinic

    Learn about the symptoms, causes and treatment of this inherited blood disorder that, in the United States, is more common among Black people.

  9. Publications - Scott C. Palmer, M.D. - Mayo Clinic

    Palmer SC, Jimenez AA. Peripheral nerve stimulation for treatment of postherpetic neuralgia: A Case report. Acta Medica Academia. 2011; 40(2):187-91. Freeman ...

  10. A Study to Compare Subcutaneous Daratumumab with Intravenous Daratumumab - Mayo Clinic

    ... SC therapies. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...